Conmed Corp.
CNMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.47B
Close$
$143.09
187.2% upside
Current Fair Value
187.2% upsideUndervalued by 187.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.47 Billion |
|---|---|
| Enterprise Value | $2.27 Billion |
| Dividend Yield | $0.80 (0.41%) |
| Earnings per Share | $1.52 |
| Beta | 0.93 |
| Outstanding Shares | 30,069,000 |
Return
| Return on Equity | 5.43% |
|---|---|
| Return on Assets | 2.46% |
| Return on Invested Capital | 6.26% |
Valuation & Multiples
| P/E Ratio | 26.52 |
|---|---|
| PEG | 344.25 |
| Price to Sales | 1.11 |
| Price to Book Ratio | 1.47 |
| Enterprise Value to Revenue | 1.65 |
| Enterprise Value to EBIT | 19.64 |
| Enterprise Value to Net Income | 40 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.8 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
$1.11
Average shareholder expectationRevenue Estimate
$337.60 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$1.01
Average shareholder expectationRevenue Estimate
$336.15 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 37.60% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 31.20%▼ 78.70% |
|---|---|
| Total Invested | $312.21M▼ 74.11% |
| Investors Holding | 92▼ 148.00% |
ESG Score
No data
About Conmed Corp.
CEO: Curt Hartman